Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Contents
Current Drug Targets, Volume 3 - Number 5
The Secreted Aspartic Proteinases as a New Target in the Therapy of Candidiasis
, 3(5): 351 - 357M. Bein, M. Schaller and H.C. Korting
DOI: 10.2174/1389450023347542
ETS Proteins and MMPs: Partners in Invasion and Metastasis
, 3(5): 359 - 367Sadmeet Singh, Jane Barrett, Kenji Sakata, Richard G. Tozer and Gurmit Singh
DOI: 10.2174/1389450023347489
Therapeutic Strategies for Hepatitis B virus-Associated Hepatocellular Carcinoma
, 3(5): 369 - 378Ee-Tsin Wong, Yat-Peng Chew, Linda A. Lee and Caroline G.L. Lee
DOI: 10.2174/1389450023347506
HMG-Co A Reductase Inhibitors in the Treatment of Cardiovascular Diseases: Stabilization of Coronary Artery Plaque
, 3(5): 379 - 385Ryuichi Morishita, Naruya Tomita and Toshio Ogihara
DOI: 10.2174/1389450023347434
Tumor Cell-Based Vaccination in Renal Cell Carcinoma: Rationale,Approaches, and Recent Clinical Development
, 3(5): 401 - 408Johannes Volk, Saadettin Sel, Arnold Ganser and Patrick Schoffski
DOI: 10.2174/1389450023347524
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net